X

Clinical Trials

Contact Us

NRG-GU005 (NCT03367702)

Study Number: NRG-GU005 (NCT03367702)

Phase III IGRT and SBRT versus IGRT and Hypofranctionated IMRT for Localized Intermediate Risk Prostate Cancer

Please Note:

Requires RT credentialing prior to patient registration. MBMC approved.

Contact Person(s)
  • MBMC, Brandi Koziatek, 314-996-5898

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.